ACCOUNTS - Final Accounts


Caseware UK (AP4) 2020.0.247 2020.0.247 2021-08-312021-08-31false2020-09-01No description of principal activity11falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 05974094 2020-09-01 2021-08-31 05974094 2019-09-01 2020-08-31 05974094 2021-08-31 05974094 2020-08-31 05974094 c:Director1 2020-09-01 2021-08-31 05974094 d:PatentsTrademarksLicencesConcessionsSimilar 2021-08-31 05974094 d:PatentsTrademarksLicencesConcessionsSimilar 2020-08-31 05974094 d:Goodwill 2020-09-01 2021-08-31 05974094 d:Goodwill 2021-08-31 05974094 d:Goodwill 2020-08-31 05974094 d:CopyrightsPatentsTrademarksServiceOperatingRights 2021-08-31 05974094 d:CopyrightsPatentsTrademarksServiceOperatingRights 2020-08-31 05974094 d:CurrentFinancialInstruments 2021-08-31 05974094 d:CurrentFinancialInstruments 2020-08-31 05974094 d:Non-currentFinancialInstruments 2021-08-31 05974094 d:Non-currentFinancialInstruments 2020-08-31 05974094 d:CurrentFinancialInstruments d:WithinOneYear 2021-08-31 05974094 d:CurrentFinancialInstruments d:WithinOneYear 2020-08-31 05974094 d:Non-currentFinancialInstruments d:AfterOneYear 2021-08-31 05974094 d:Non-currentFinancialInstruments d:AfterOneYear 2020-08-31 05974094 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2021-08-31 05974094 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2020-08-31 05974094 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2021-08-31 05974094 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2020-08-31 05974094 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2021-08-31 05974094 d:Non-currentFinancialInstruments d:MoreThanFiveYears 2020-08-31 05974094 d:ShareCapital 2021-08-31 05974094 d:ShareCapital 2020-08-31 05974094 d:RetainedEarningsAccumulatedLosses 2021-08-31 05974094 d:RetainedEarningsAccumulatedLosses 2020-08-31 05974094 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2021-08-31 05974094 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2020-08-31 05974094 c:FRS102 2020-09-01 2021-08-31 05974094 c:AuditExempt-NoAccountantsReport 2020-09-01 2021-08-31 05974094 c:FullAccounts 2020-09-01 2021-08-31 05974094 c:PrivateLimitedCompanyLtd 2020-09-01 2021-08-31 05974094 d:WithinOneYear 2021-08-31 05974094 d:WithinOneYear 2020-08-31 05974094 d:BetweenOneFiveYears 2021-08-31 05974094 d:BetweenOneFiveYears 2020-08-31 05974094 d:PatentsTrademarksLicencesConcessionsSimilar d:ExternallyAcquiredIntangibleAssets 2020-09-01 2021-08-31 05974094 d:Goodwill d:ExternallyAcquiredIntangibleAssets 2020-09-01 2021-08-31 05974094 d:CopyrightsPatentsTrademarksServiceOperatingRights d:ExternallyAcquiredIntangibleAssets 2020-09-01 2021-08-31 05974094 6 2020-09-01 2021-08-31 05974094 d:ExternallyAcquiredIntangibleAssets 2020-09-01 2021-08-31 iso4217:GBP xbrli:pure

Registered number:  05974094














APOLLO GENERICS LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2021


 
APOLLO GENERICS LIMITED
REGISTERED NUMBER: 05974094

STATEMENT OF FINANCIAL POSITION
AS AT 31 AUGUST 2021

2021
2020
Note
£
£

Fixed assets
  

Intangible assets
 4 
444,593
442,410

Investments
 5 
10,000
10,000

  
454,593
452,410

Current assets
  

Debtors: amounts falling due within one year
 6 
32,084
24,756

Cash at bank and in hand
 7 
2,798
1,382

  
34,882
26,138

Creditors: amounts falling due within one year
 8 
(297,536)
(295,234)

Net current liabilities
  
 
 
(262,654)
 
 
(269,096)

Total assets less current liabilities
  
191,939
183,314

Creditors: amounts falling due after more than one year
 9 
(48,262)
(54,787)

  

Net assets
  
143,677
128,527


Capital and reserves
  

Called up share capital 
  
50,002
50,002

Profit and loss account
  
93,675
78,525

  
143,677
128,527


Page 1

 
APOLLO GENERICS LIMITED
REGISTERED NUMBER: 05974094
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 AUGUST 2021

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 1 March 2022.






R. A. Rawlinson
Director

The notes on pages 3 to 11 form part of these financial statements.

Page 2

 
APOLLO GENERICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2021

1.


General information

Apollo Generics Limited is a private limited company, limited by shares, incorporated in England and Wales. It's registered office is Unit 1 76 Stephenson Way, Formby Business Park, Liverpool, Merseyside, L37 8EG. The company number is 05974094.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Going concern

The company has a bank loan and the directors have a reasonable expectation that the company has adequate resources to make its bank loan repayments and continue in operational existence for the foreseeable future. They continue to believe the going concern basis of accounting appropriate in preparing the annual financial statements.

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the statement of income and retained earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
APOLLO GENERICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2021

2.Accounting policies (continued)

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Page 4

 
APOLLO GENERICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2021

2.Accounting policies (continued)

 
2.8

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the statement of income and retained earnings over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.9

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.10

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.12

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.13

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid
Page 5

 
APOLLO GENERICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2021

2.Accounting policies (continued)


2.13
Financial instruments (continued)

or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the statement of income and retained earnings.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the reporting date.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2020 - 1).

Page 6

 
APOLLO GENERICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2021

4.


Intangible assets




Product licenses
Trademarks
Goodwill
Total

£
£
£
£



Cost


At 1 September 2020
434,197
8,209
4
442,410


Additions
2,183
-
-
2,183



At 31st August 2021

436,380
8,209
4
444,593






Net book value



At 31st August 2021
436,380
8,209
4
444,593



At 31st August 2020
434,197
8,209
4
442,410




5.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 September 2020
10,000



At 31st August 2021
10,000





6.


Debtors

2021
2020
£
£


Other debtors
6,524
1,953

Prepayments and accrued income
25,560
22,803

32,084
24,756


Page 7

 
APOLLO GENERICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2021

7.


Cash and cash equivalents

2021
2020
£
£

Cash at bank and in hand
2,798
1,382

2,798
1,382



8.


Creditors: Amounts falling due within one year

2021
2020
£
£

Bank loans
9,261
24,006

Trade creditors
125,538
158,836

Amounts owed to group undertakings
41,572
40,787

Corporation tax
7,732
7,915

Other taxation and social security
6,730
7,776

Other creditors
104,443
53,550

Accruals and deferred income
2,260
2,364

297,536
295,234


Bank loans amounting to £7,206 (2020 - £21,654) are secured by a fixed a floating charge over all the assets of the company, a £100,000 guarantee given by the director, R. A. Rawlinson and a unlimited composite guarantee given by the subsidiary company, Zanza Specials International Limited.

Page 8

 
APOLLO GENERICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2021

9.


Creditors: Amounts falling due after more than one year

2021
2020
£
£

Bank loans
48,262
54,787

48,262
54,787


Bank loans amounting to £Nil (2020 - £7,140) are secured by a fixed a floating charge over all the assets of the company, a £100,000 guarantee given by the director, R. A. Rawlinson and a unlimited composite guarantee given by the subsidiary company, Zanza Specials International Limited.

The aggregate amount of liabilities repayable wholly or in part more than five years after the reporting date is:

2021
2020
£
£


Repayable by instalments
25,522
7,904

25,522
7,904

Bank loans falling due after five years are repayable by monthly instalments commencing May 2022 and interest is charged at a rate of 2.5% per annum.

Page 9

 
APOLLO GENERICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2021

10.


Loans


Analysis of the maturity of loans is given below:


2021
2020
£
£

Amounts falling due within one year

Bank loans
9,261
24,006


9,261
24,006

Amounts falling due 1-2 years

Bank loans
5,474
16,707


5,474
16,707

Amounts falling due 2-5 years

Bank loans
17,265
30,176


17,265
30,176

Amounts falling due after more than 5 years

Bank loans
25,522
7,904

25,522
7,904

57,522
78,793



11.


Financial instruments

2021
2020
£
£

Financial assets


Financial assets measured at fair value through profit or loss
2,798
1,382




Financial assets measured at fair value through profit or loss comprise cash and cash equivalents.

Page 10

 
APOLLO GENERICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST AUGUST 2021

12.


Commitments under operating leases

At 31st August 2021 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2021
2020
£
£


Not later than 1 year
14,000
14,000

Later than 1 year and not later than 5 years
12,833
26,833

26,833
40,833


13.


Controlling party

The controlling party of the company is R. A. Rawlinson and W. I. Rawlinson.

 
Page 11